The Next Phase Home


Experience: Testimonials

Listen to the “voice of our customers” to help you decide if The Next Phase is the right consulting firm with the right solutions at the right time for you.

From Richard Klein, CEO Mycosol, Inc. (formerly, CEO of Angiosonics, Inc.):

The Next Phase's quick assessment of our technology and competitive situation was 'spot on.' Vicky is a consummate professional and has proved, on several occasions, that she understands the dynamics of product and market development. Her observations, comments, and guidance helped better focus our strategic planning process. Thereafter, I've recommended TNP to numerous business colleagues, several of whom have subsequently used her services. The feedback to me has been consistent: "Excellent. Thank you for the referral."


From Russell D. Van Zandt, President of ELA Medical (formerly CEO of CardioLogic Systems, Inc.)

Our work with The Next Phase was more than satisfying. We found the work to be extremely thorough and comprehensive as well as timely. I would strongly recommend The Next Phase in any aspect of medical technology assessment, planning, development and execution.


From Jan Price, Vice President of Marketing International Technidyne Corporation

The results from the Next Phase are always completely thorough. TNP's team and Vicky Hunsicker Sanko, its founder, have excellent follow-up and communication skills. In particular, Vicky goes the extra mile to make sure the client is informed and has appropriate insight every step of the way.


From Aaron Feldman, CEO Rafael Medical Technologies, Inc.

The [Next Phase's] market research project was useful in that it provided us and our investors with a more objective measure of the demand for our product and also was useful in helping us better define our device and end user segments.


From Paul Molloy, Senior Vice President of Sales and Marketing, Endologix, Inc. (formerly Executive VP Radiance Medical Systems):

I was just browsing another section of the 'restenosis' report - this time on drug delivery. Let me say again what a tremendous job your team has done on this! It is a huge amount of work, extremely thorough and well laid out. The purchase has been a very worthwhile investment, from my perspective. I will be briefing our board of directors next week on strategic investment opportunities for our company in this area and the data you have summarized has been invaluable in preparing for this.


From Cheryl Liberatore, Director of Corporate Development REVA Medical.

The Next Phase's Restenosis Report was very comprehensive and the information was categorized in a user-friendly manner. It provided a wonderful foundation for fully understanding the interventional cardiology market, particularly the developing area of drug-eluting stents.

In addition, The Next Phase was able to quickly provide a follow-up, customized market research report on specific areas where we wanted more detailed information. The cost/value ratio was very positive.


We would highly recommend TNP to any of its prospective clients.

We invite you to contact us if you are

Ready for growth... Ready for The Next Phase

Last modified November 3, 2003


SERVICES | EXPERIENCE | PUBLICATIONS | ABOUT US | OUTSIDE U.S.
Our Partners | Search | Contact | Privacy | Home

The Next Phase Consultancy, Inc.
Phone: 425.869.8724 / Fax: 425.869.9397
e-mail:

Trademark information:
The Next Phase and The Next Phase "Moons" logo are registered trademarks, and The Next Phase SMArt Chart, CPI, PTMA, SMA, TNP and TNP SMArt Chart are trademarks of The Next Phase Consultancy, Inc. Send mail to , with questions or comments about this web site.

Copyright © 2007 The Next Phase Consultancy, Inc. All rights reserved.

Inside Experience

Our Clients
Market Knowledge
Technology Knowledge
Testimonials
Our Partners